鴻洺科技-腎癌、輸尿管 TMA

上海芯超生物科技有限公司
生物芯片上海国家工程研究中心

上海市高新技術企業

上海芯超生物科技有限公司成立於2003年12月18日

為美國BIOXXX 組織晶片公司之上游供應商

擁有十五863消化道腫瘤組織庫與組織芯片重大項目、十一五863胰腺癌基因組重大項目、衛生部肝癌組織芯片分子標記物篩選重大項目、863胃癌易感基因與幽門螺桿菌耐藥基因聯合檢測重點項目。

商品介紹

Catalog	Diameter	Dots	Cases	Description
HKidC080PT01 (kidney)	1.5mm	80	40	40 cases of renal cell carcinoma, clear cell cancer, papillary cell carcinoma, chromophobe cell carcinoma, real cystic renal cell carcinoma, Bellini collection duct carcinoma, nephroblastoma, mucinous tubular and spindle cell carcinoma.
HKid-CRC030PG-01 (kidney)	2.0mm	30	15	1. kidney clear cell carcinoma (15 cases), Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case). 2. Pathology grade 2
HKid-CRC060CS-01 (kidney)	2.0mm	60	30	1.25 cases Renal clear cell carcinoma, tumor with matched normal adjacent tissue(or remote tissue/NAT/tumor) 2.Clinical stage(AJCC 7.0)I II III IV 3.5 cases of kidney cancer metastases
HKid-CRC180Sur-01 (kidney)	1.5mm	180	90	1. Kidney clear cell carcinoma (90 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Survival information available. Being followed up for 5.5 - 7 years.
HKid-CRCC060PG-01 (kidney)	2.0mm	60	30	1. Kidney clear cell carcinoma (30 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Pathology grade 1 ( 1 case), 1-2(2 cases), 2 (22 cases), 3 (5 cases).
HKid-CRCC150CS-01 (kidney)	1.5mm	150	75	1. Kidney clear cell carcinoma (75 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case) 2. Clinical stage I (33 cases), II ( 24 cases), III (17 cases), IV (1 case). 3. 100% cases have TNM detail information. 4. Pathology grade 1, 2, 3. 5. 43 cases have survival information.
HKid-CRCC150CS-02 (kidney)	1.5mm	150	75	1. Kidney clear cell carcinoma (75 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case) 2. Clinical stage I (29 cases), II ( 23 cases), III (17 cases), IV (6 case). 3. 100% cases have TNM detail information. 4. Pathology grade 1, 2, 3.
HKidE030PG02 (kidney)	2.0mm	60	30	clear cell renal carcinoma 30 cases: 1 core/case, grade I-Ⅲ.
HKidE180Su02 (kidney)	1.5mm	180	150	1. Kidney clear cell carcinoma (150 cases), 150 cases of tumor (1 core/case) and 30 cases of matched normal adjacent tissue (1 core/case). 2. Survival information available. Being followed up for 5.5 - 7.5 years. visit date 2015.08
OD-CT-UrKid01-004 (kidney)	1.0mm	248	62	1. Kidney clear cell carcinoma (62 cases). 2. Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case).
OD-CT-UrKid01-005 (kidney)	1.0mm	248	62	1. Kidney carcinoma (62 cases), containing kidney clear cell carcinoma (34 cases), papillary renal cell carcinoma (20 cases), chromophobe cell carcinoma (7 cases) and oncocytoma (1 case). 2. Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case).
OD-CT-UrKid02-001 (kidney)	2.0mm	32	32	1. Kidney clear cell carcinoma (32 cases), 1 core/case. 2. Pathology grade 1.
OD-CT-UrKid03-001 (kidney)	2.0mm	62	62	1. Kidney clear cell carcinoma (62 cases), 1 core/case. 2. Pathology grade 1, 1-2, 2.
OD-CT-UrKid03-002 (kidney)	2.0mm	62	31	1. Kidney clear cell carcinoma (31 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Pathology grade 1.
OD-CT-UrKid03-003 (kidney)	2.0mm	62	31	1. Kidney carcinoma (31 cases), containing kidney clear cell carcinoma (10 cases), papillary renal cell carcinoma (11 cases), chromophobe cell carcinoma (9 cases). Tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Clinical stage I, II, III (Version 7.0). 3. 100% cases have TNM detail information. 4. Pathology grade 1, 2, 3.
OD-CT-UrKid04-001 (kidney)	1.5mm	85	40	1. Kidney clear cell carcinoma (40 cases), 2 cores/case. Normal adjacent tissue (5 cases), 1 core/case. 2. Clinical stage I, II, III (Version 7.0). 3. Pathology Grade 1, 2, 3.
HRaU-Uro120Sur-01 (kidney pelvis and ureter)	1.5mm	120	120	1. Kidney pelivis carcinoma and ureter carcinoma, 120cases. Tumor, 1 core/case 2. Survival information available. Being followed up for 0.5-7 years.